Gram-Scale Production of Ginsenoside F1 Using a Recombinant Bacterial β-Glucosidase |
An, Dong-Shan
(Biological Resource Center/Korean Collection for Type Cultures (KCTC), Korea Research Institute of Bioscience and Biotechnology)
Cui, Chang-Hao (KAIST Institute for Biocentury, Korea Advanced Institute of Science and Technology) Siddiqi, Muhammad Zubair (Department of Biotechnology, Hankyong National University) Yu, Hong Shan (College of Biotechnology, Dalian Polytechnic University) Jin, Feng-Xie (College of Biotechnology, Dalian Polytechnic University) Kim, Song-Gun (Biological Resource Center/Korean Collection for Type Cultures (KCTC), Korea Research Institute of Bioscience and Biotechnology) Im, Wan-Taek (Department of Biotechnology, Hankyong National University) |
1 | Yoo DS, Rho HS, Lee YG, Yeom MH, Kim DH, Lee SL, et al. 2011. Ginsenoside F1 modulates cellular responses of skin Melanoma Cells. J. Ginseng Res. 35: 86-91. DOI |
2 | Lee EH, Cho SY, Kim SJ, Shin ES, Chang HK, Kim DH, et al. 2003. Ginsenoside F1 protects human HaCaT keratinocytes from ultraviolet-B-induced apoptosis by maintaining constant levels of Bcl-2. J. Invest. Dermatol. 121: 607-613. DOI |
3 | Ko SR, Choi KJ, Suzuki K, Suzuki Y. 2003. Enzymatic preparation of ginsenosides Rg2, Rh1, and F1. Chem. Pharm. Bull. 51: 404-408. DOI |
4 |
Kim YS, Yoo MH, Lee GW, Choi JG, Kim KR, Oh DK. 2011. Ginsenoside F1 production from ginsenoside Rg1 by a purified |
5 | Wang D, Yu H, Song J, Xu Y, Jin F. 2012. Enzyme kinetics of ginsenosidase type IV hydrolyzing 6-O-multi-glycosides of protopanaxatriol type ginsenosides. Process Biochem. 47: 133-138. DOI |
6 |
Wei Y, Zhao W, Zhang Q, Zhao Y, Zhang Y. 2011. Purification and characterization of a novel and unique ginsenoside Rg 1-hydrolyzing |
7 |
An DS, Cui CH, Sung BH, Yang HC, Kim SC, Lee ST, et al. 2012. Characterization of a novel ginsenoside-hydrolyzing |
8 | An DS, Cui CH, Lee HG, Wang L, Kim SC, Lee ST, et al. 2010. Identification and characterization of a novel Terrabacter ginsenosidimutans sp. nov. beta-glucosidase that transforms ginsenoside Rb1 into the rare gypenosides XVII and LXXV. Appl. Environ. Microbiol. 76: 5827-5836. DOI |
9 | Lee CH, Kim JH. 2014. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J. Ginseng Res. 38: 161-166. DOI |
10 | Bae M, Jang S, Lim JW, Kang J, Bak EJ, Cha JH, et al. 2014. Protective effect of Korean Red Ginseng extract against Helicobacter pylori-induced gastric inflammation in Mongolian gerbils. J. Ginseng Res. 38: 8-15. DOI |
11 | Park HJ, Kim DH, Park SJ, Kim JM, Ryu JH. 2012. Ginseng in traditional herbal prescriptions. J. Ginseng Res. 36: 225-241. DOI |
12 | Christensen LP. 2008. Ginsenosides. Chemistry, biosynthesis, analysis, and potential health effects. Adv. Food Nutr. Res. 55: 1-99. |
13 | Corbit RM, Ferreira JF, Ebbs SD, Murphy LL. 2005. Simplified extraction of ginsenosides from American ginseng (Panax quinquefolius L.) for high-performance liquid chromatographyultraviolet analysis. J. Agric. Food Chem. 53: 9867-9873. DOI |
14 | Nguyen H T, S ong GY, Kim JA, H yun JH, Kang H K, K im YH. 2010. D ammarane-type saponins f rom the f lower buds of Panax ginseng and their effects on human leukemia cells. Bioorg. Med. Chem. Lett. 20: 309-314. DOI |
15 | Qu C, Bai Y, Jin X, Wang Y, Zhang K, You J, et al. 2009. Study on ginsenosides in different parts and ages of Panax quinquefolius L. Food Chem. 115: 340-346. DOI |
16 | Shi W, Wang Y, Li J, Zhang H, Ding L. 2007. Investigation of ginsenosides in different parts and ages of Panax ginseng. Food Chem. 102: 664-668. DOI |
17 | Baek NI, Kim DS, Lee YH, Park JD, Lee CB, Kim SI. 1995. Cytotoxicities of ginseng saponins and their degradation products against some cancer cell lines. Arch. Pharm. Res. 18: 164-168. DOI |
18 | Hasegawa H. 2004. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J. Pharmacol. Sci. 95: 153-157. DOI |
19 | Akao T, Kanaoka M, Kobashi K. 1998. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration - measurement of compound K by enzyme immunoassay. Biol. Pharm. Bull. 21: 245-249. DOI |
20 | Liu Y, Zhang JW, Li W, Ma H, Sun J, Deng MC, Yang L. 2006. Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes. Toxicol. Sci. 91: 356-364. DOI |
21 | Popovich DG, Kitts DD. 2004. Generation of ginsenosides Rg3 and Rh2 from North American ginseng. Phytochemistry 65: 337-344. DOI |
22 | Park CS, Yoo MH, Noh KH, Oh DK. 2010. Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases. Appl. Microbiol. Biotechnol. 87: 9-19. DOI |
23 | Siddiqi MZ, Siddiqi MH, Kim YJ, J in Y, Huq MA, Yang DC. 2015. Effect of fermented red ginseng extract enriched in ginsenoside Rg3 on the differentiation and mineralization of preosteoblastic MC3T3-E1 cells. J. Med. Food 18: 1-7. DOI |
24 | Wang Y, Choi KD, Yu H, Jin F, Im WT. 2016. Production of ginsenoside F1 using commercial enzyme Cellulase KN. J. Ginseng Res. 40: 121-126. DOI |
![]() |